CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Is Regeneron Pharmaceuticals, Inc. (REGN) Stock Still a Biotech Leader After Analyst Price Target Cut?

Negative
AI Analysis

Summary

An analyst has issued a price target cut for Regeneron Pharmaceuticals (REGN). The article discusses the company's status as a biotech leader in light of this analyst action.

Importance:2/10
Sentiment:
-0.30
analyst_ratingprice_target_cutstock_performance
Related Companies

Read the original article

Published by yahoo_finance on July 8, 2026 2:50 PM

Read Original